Skip to main content
SpringerLink
Log in

Binding of imipramine to plasma protein and to brain tissue: Relationship to CSF tricyclic levels in man

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The possible clinical significance of the plasma protein binding of tricyclic antidepressants has been evaluated using imipramine (IMI), a typical tricyclic. Using equilibrium dialysis, the in vitro binding of IMI to plasma was compared to that of brain tissue. Cerebrospinal fluid (CSF) IMI was used as an independent measure of “free” drug in the central nervous system. Intrinsic metabolic clearances were calculated on the basis of steady-state plasma IMI concentrations. There were three significant results: (1) variations in plasma binding are not great; (2) plasma protein binding does not limit the entry of IMI into the CSF; (3) variations in metabolism (intrinsic clearance) account for almost all variations in CSF concentrations of drug. It is concluded that measurement of free tricyclic antidepressant is not indicated in studies of clinical efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alexanderson, B., Price-Evans, D. A., Sjoqvist, F.: Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br. Med. J. 4, 764–768 (1969)

    Google Scholar 

  • Alexanderson, B., Borga, O.: Interindividual differences in plasma protein binding of nortriptyline in man—a twin study. Eur. J. Clin. Pharmacol. 4, 196–200 (1972)

    Google Scholar 

  • Asberg, M.: Treatment of depression with tricyclic drugs pharmacokinetic and pharmacodynamic aspects. Pharmacopsychiatry 9, 18–26 (1976)

    Google Scholar 

  • Ballenger, B. R., Presly, A., Reid, A. H., Stevensen, I. H.: The effects of hypnotics on imipramine treatment. Psychopharmacologia 39, 267–274 (1974)

    Google Scholar 

  • Bickel, M. H.: Poisoning by tricyclic antidepressant drugs. Int. J. Clin. Pharmacol. Ther. Toxicol. 11, 145–176 (1975)

    Google Scholar 

  • Bickel, M. H., Steele, J. W.: Binding of basic and acidic drugs to rat tissue subcellular fractions. Chem. Biol. Interact. 8, 151–162 (1974)

    Google Scholar 

  • Biggs, J. T., Chang, S. S., Sherman, W. R., Holland, W. H.: Measurement of tricyclic antidepressant levels in an outpatient clinic. J. Nerv. Ment. Dis. 162, 46–51 (1976)

    Google Scholar 

  • Borga, O., Azarnoff, D. L., Forshell, G., Sjoqvist, F.: Plasma protein binding of tricyclic antidepressants in man. Biochem. Pharmacol. 18, 2135–2143 (1969)

    Google Scholar 

  • Borga, O., Piafsky, K. M.: Plasma protein binding of basic drugs. II. Importance of α-acid glycoprotein for interindividual variation. Clin. Pharmacol. Ther. 22, 545–549 (1977)

    Google Scholar 

  • Borga, O., Piafsky, K. M., Nilsen, O. G.: Plasma protein binding of basic drugs. I. Selective displacement from α-acid glycoprotein by this (2-butoxyethyl) phosphate. Clin. Pharmacol. Ther. 22, 539–544 (1977)

    Google Scholar 

  • Campbell, I. C., Todrick, A.: Plasma protein binding of tricyclic antidepressive drugs. J. Pharm. Pharmacol. 22, 226–227 (1970)

    Google Scholar 

  • Claeys, M., Muscettola, G., Markey, S. P.: Simultaneous determination of imipramine and desipramine by selected ion recording with deuterated internal standards. Biomed. Mass. Spectrom. 3, 110–116 (1976)

    Google Scholar 

  • Curry, S. H.: Theoretical changes in drug distribution resulting from changes in binding to plasma proteins and to tissue. J. Pharm. Pharmacol. 22, 753–757 (1970)

    Google Scholar 

  • Glassman, A. H., Hurwic, M. J., Perel, J. M.: Plasma binding of imipramine and clinical outcome. Am. J. Psychiat. 130, 1367–1369 (1973)

    Google Scholar 

  • Glassman, A. H., Perel, J. M., Shostalk, M., Kantor, S. J., Fleiss, J. L.: Clinical implications of imipramine plasma levels for depressive illness. Arch. Gen. Psychiatry 34, 197–204 (1977)

    Google Scholar 

  • Goodwin, F. K., Post, R. M., Dunner, D. L., Gordon, E. K.: Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. Am. J. Psychiatry 130, 73–79 (1973)

    Google Scholar 

  • Gram, L. F., Reisby, N., Ibsen, I., Nagy, A., Dencker, S. J., Bech, P., Petersen, G. O., Christiansen, J.: Plasma levels and antidepressive effect of imipramine. Clin. Pharmacol. Ther. 19, 318–324 (1976)

    Google Scholar 

  • Jusko, W. J., Gretch, M.: Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab. Rev. 5, 43–140 (1976)

    Google Scholar 

  • Kragh-Sorensen, P., Hansen, C. E., Baastrup, P. C., Hvidberg, E. F.: Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels. Psychopharmacologia 45, 305–312 (1976)

    Google Scholar 

  • Lowry, O., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265–275 (1951)

    Google Scholar 

  • Lund, L., Berlin, A., Lunde, K. M.: Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluid. Clin. Pharmacol. Ther. 13, 196–200 (1972)

    Google Scholar 

  • Muscettola, G., Goodwin, F. K., Potter, W. Z., Claeys, M. M., Markey, S. P.: Imipramine and desimipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism. Arch. Gen. Psychiatry 35, 609–615 (1978)

    Google Scholar 

  • Nies, A., Robinson, D. S., Friedman, M. J., Green, R., Cooper, T. B., Ravaris, C. L., Ives, J. O.: Relationship between age and tricyclic antidepressant plasma levels. Am. J. Psychiatry 134, 790–793 (1977)

    Google Scholar 

  • Perel, J. M., Shostak, M., Gann, E., Kantor, S. J., Glassman, A. H.: Pharmacodynamics of imipramine and clinical outcome. In: Pharmacokinetics of psychoactive drugs, L. A. Gottschalk and S. Merlis, eds., pp. 229–241. New York, Spectrum Publications 1976

    Google Scholar 

  • Pruitt, A. W., Dayton, P. G.: A comparison of the binding of drugs to adult and cord plasma. Europ. J. Clin. Pharmacol. 4, 59–62 (1971)

    Google Scholar 

  • Sjoqvist, F.: A pharmacokinetic approach to the treatment of depression. Int. Pharmacopsychiatry 6, 147–169 (1971)

    Google Scholar 

  • Taska, R. J.: Clinical laboratory aids in the treatment of depression: tricyclic antidepressant plasma levels and urinary MHPG. Curr. Concepts Psychiatry 3, 12–20 (1977)

    Google Scholar 

  • Weder, H. J., Bickel, M. H.: Interactions of drugs with proteins. I. Bindings of tricyclic thymoleptics to human and bovine plasma proteins. J. Pharmacol. Sci. 59, 1505–1507 (1970)

    Google Scholar 

  • Wilkinson, G. R., Shand, D. G.: A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther. 18, 377–390 (1975)

    Google Scholar 

  • Ziegler, V. E., Clayton, P. S., Biggs, J. T.: A comparison study of amitriptyline and nortriptyline with plasma levels. Arch. Gen. Psychiatry 34, 607–615 (1977)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Psychobiology Branch, National Institute of Mental Health, 9000 Rockville Pike, Building 10, Room 4S239, 20014, Bethesda, Maryland, USA

    William Z. Potter, Giovanni Muscettola & Frederick K. Goodwin

Authors
  1. William Z. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Muscettola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frederick K. Goodwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Potter, W.Z., Muscettola, G. & Goodwin, F.K. Binding of imipramine to plasma protein and to brain tissue: Relationship to CSF tricyclic levels in man. Psychopharmacology 63, 187–192 (1979). https://doi.org/10.1007/BF00429700

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00429700

Key words

Search

Navigation